Regen BioPharma's market value is the price at which a share of Regen BioPharma trades on a public exchange. It measures the collective expectations of Regen BioPharma investors about its performance. Regen BioPharma is selling at 0.0022 as of the 14th of February 2026; that is 24.14 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 0.0022. With this module, you can estimate the performance of a buy and hold strategy of Regen BioPharma and determine expected loss or profit from investing in Regen BioPharma over a given investment horizon. Check out Regen BioPharma Correlation, Regen BioPharma Volatility and Regen BioPharma Performance module to complement your research on Regen BioPharma.
It's important to distinguish between Regen BioPharma's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Regen BioPharma should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Regen BioPharma's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Regen BioPharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Regen BioPharma's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Regen BioPharma.
0.00
11/16/2025
No Change 0.00
0.0
In 3 months and 1 day
02/14/2026
0.00
If you would invest 0.00 in Regen BioPharma on November 16, 2025 and sell it all today you would earn a total of 0.00 from holding Regen BioPharma or generate 0.0% return on investment in Regen BioPharma over 90 days. Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States More
Regen BioPharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Regen BioPharma's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Regen BioPharma upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Regen BioPharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Regen BioPharma's standard deviation. In reality, there are many statistical measures that can use Regen BioPharma historical prices to predict the future Regen BioPharma's volatility.
Regen BioPharma is out of control given 3 months investment horizon. Regen BioPharma maintains Sharpe Ratio (i.e., Efficiency) of 0.0633, which implies the firm had a 0.0633 % return per unit of risk over the last 3 months. We were able to interpolate data for twenty-eight different technical indicators, which can help you to evaluate if expected returns of 2.46% are justified by taking the suggested risk. Use Regen BioPharma Risk Adjusted Performance of 0.0572, coefficient of variation of 1700.49, and Semi Deviation of 25.83 to evaluate company specific risk that cannot be diversified away. Regen BioPharma holds a performance score of 5 on a scale of zero to a hundred. The company holds a Beta of 9.79, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Regen BioPharma will likely underperform. Use Regen BioPharma sortino ratio and the relationship between the downside variance and price action indicator , to analyze future returns on Regen BioPharma.
Auto-correlation
0.46
Average predictability
Regen BioPharma has average predictability. Overlapping area represents the amount of predictability between Regen BioPharma time series from 16th of November 2025 to 31st of December 2025 and 31st of December 2025 to 14th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Regen BioPharma price movement. The serial correlation of 0.46 indicates that about 46.0% of current Regen BioPharma price fluctuation can be explain by its past prices.
Correlation Coefficient
0.46
Spearman Rank Test
0.51
Residual Average
0.0
Price Variance
0.0
Pair Trading with Regen BioPharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Regen BioPharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regen BioPharma will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Regen BioPharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Regen BioPharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Regen BioPharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Regen BioPharma to buy it.
The correlation of Regen BioPharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Regen BioPharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Regen BioPharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Regen BioPharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
When running Regen BioPharma's price analysis, check to measure Regen BioPharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regen BioPharma is operating at the current time. Most of Regen BioPharma's value examination focuses on studying past and present price action to predict the probability of Regen BioPharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regen BioPharma's price. Additionally, you may evaluate how the addition of Regen BioPharma to your portfolios can decrease your overall portfolio volatility.